PRPH - ProPhase Labs, Inc. Stock Analysis | Stock Taper
Logo

About ProPhase Labs, Inc.

https://www.prophaselabs.com

ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products.

Ted William Karkus

CEO

Ted William Karkus

Compensation Summary
(Year 2024)

Salary $675,000
Bonus $200,000
Option Awards $1,220,000
All Other Compensation $28,200
Total Compensation $2,123,200
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Went public April 4, 1994
Method of going public IPO
Full time employees 96

Split Record

Date Type Ratio
2025-12-22 Reverse 1:10
1997-01-23 Forward 2:1

ETFs Holding This Stock

Summary

Total 1

Showing Top 1 of 1

Ratings Snapshot

Rating : D+

Discounted Cash Flow 1
Return On Equity 1
Return On Assets 1
Debt To Equity 1
Price To Earnings 1
Price To Book 1
Overall Score 1

Price Target

Target High $14
Target Low $14
Target Median $14
Target Consensus $14

Institutional Ownership